Factor V leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis

Annals of Neurology

Volumn 42, Issue 3, 1997, Pages 372-375

  Thorarensen, Olafur ^a   Ryan, Stephen ^a   Hunter, Jill ^a,b   Younkin, Donald P ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ARGININE; BLOOD CLOTTING FACTOR 5; GLUTAMINE;

ARTICLE; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN VENTRICLE DILATATION; CASE REPORT; CEREBRAL PALSY; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HEMIPLEGIA; HUMAN; INFANT; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA DISORDER; PRIORITY JOURNAL; STROKE; THROMBOSIS;

BRAIN ISCHEMIA; CEREBRAL PALSY; CEREBROVASCULAR DISORDERS; FACTOR V; FEMALE; HEMIPLEGIA; HUMANS; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; PLACENTA; POINT MUTATION; PREGNANCY; PROTEIN C; THROMBOSIS;

EID: 0030767010     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420316     Document Type: Article

References (20)

1. Zöller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994:343:1536-1538
2. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994:369:64-67
3. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994:330:517-522
4. Ridker PM, Hennekens CH, Lindpainter K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995:332:912-917
5. Simioni P, de Ronde H, Prandoni P, et al. Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 1995; 26:885-890
6. Ganesan V, Kelsey H, Cookson J, et al. Activated protein C resistance in childhood stroke. Lancet 1996:347:260 (Letter)
7. Nowak-Göttl U, Koch HG, Aschka I, et al. Resistance to activated protein C (APC) in children with venous or arterial thromboembolism. Br J Haematol 1996;92:992-998
8. Sugimoto T, Woo M, Nishida N, et al. When do brain abnormalities in cerebral palsy occur? An MRI study. Dev Med Child Neurol 1995:37:285-292
9. Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994:94:923-927
10. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sei USA 1993:90:1004-1008
11. Sifontes MT, Nuss R, Jacobson LJ, et al. Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr 1996;128:324-328
12. Press RD, Liu XY, Beamer N, Coull BM. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. Stroke 1996;27:44-48
13. Lalouschek W, Suess E, Aull S, et al. Clinical and laboratory data in heterozygous factor V leiden mutation positive versus negative patients with TIA and minor stroke. Stroke 1995:26: 1963-1964 (Letter)
14. Halbmayer WM, Haushofer A, Schön R, Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stoke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinolysis 1994:5:51-57
15. Marlar RA, Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Haemost 1990;16:299-309
16. Zöller B, Svenson PJ, He X, et al. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994:94:2521-2524
17. Bokarewa MI, Bremme K, Blombäck M. Arg 506-Gln mutation in factor V and risk of thrombosis during pregnancy. Br J Hematol 1996:92:473-478
18. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995:74:415-425
19. Mandel H, Brenner B, Berant M, et al. Coexistence of hereditary homocystinuria and factor V Leiden-effect on thrombosis. N Engl J Med 1996:334:763-768
20. Gersell DJ. Selected vascular lesions of the placenta. Clin Lab Med 1995:15:611-629